Literature DB >> 1887238

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: further clarifications.

G J LaRosa1, K Weinhold, A T Profy, A J Langlois, G R Dreesman, R N Boswell, P Shadduck, D P Bolognesi, T J Matthews, E A Emini.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1887238     DOI： 10.1126/science.1887238

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  8 in total

1.  The v3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope.

Authors:  Miroslaw K Gorny; Kathy Revesz; Constance Williams; Barbara Volsky; Mark K Louder; Christopher A Anyangwe; Chavdar Krachmarov; Samuel C Kayman; Abraham Pinter; Arthur Nadas; Phillipe N Nyambi; John R Mascola; Susan Zolla-Pazner
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

2.  Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis.

Authors:  Ralph Pantophlet; Rowena O Aguilar-Sino; Terri Wrin; Lisa A Cavacini; Dennis R Burton
Journal:  Virology       Date:  2007-04-06       Impact factor: 3.616

3.  Covariation of mutations in the V3 loop of human immunodeficiency virus type 1 envelope protein: an information theoretic analysis.

Authors:  B T Korber; R M Farber; D H Wolpert; A S Lapedes
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

4.  Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection.

Authors:  L Q Zhang; P MacKenzie; A Cleland; E C Holmes; A J Brown; P Simmonds
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

5.  V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability.

Authors:  L Milich; B Margolin; R Swanstrom
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

6.  Effect of different donor cells on human immunodeficiency virus type 1 replication and selection in vitro.

Authors:  A I Spira; D D Ho
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

7.  Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades.

Authors:  Miroslaw K Gorny; Constance Williams; Barbara Volsky; Kathy Revesz; Sandra Cohen; Victoria R Polonis; William J Honnen; Samuel C Kayman; Chavdar Krachmarov; Abraham Pinter; Susan Zolla-Pazner
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Novel small synthetic HIV-1 V3 crown variants: CCR5 targeting ligands.

Authors:  Anju Krishnan Anitha; Pratibha Narayanan; Neethu Ajayakumar; Krishnankutty Chandrika Sivakumar; Kesavakurup Santhosh Kumar
Journal:  J Biochem       Date:  2022-09-05       Impact factor: 3.241
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.